← Back to Analyst Consensus 
TPST Buy
Tempest Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 24, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jan 22, 2026 | HC Wainwright & Co. | upgrade | Neutral → Buy | $11 | 44% |
| Apr 10, 2025 | Scotiabank | downgrade | Sector Outperform → Sector Perform | $9 | 55% |
| Apr 10, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $16 | 44% |
| Mar 28, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $7 | 55% |
| Mar 28, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Nov 13, 2024 | Piper Sandler | maintain | Overweight → Overweight | $5 | 54% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| Oct 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| Aug 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| Jun 21, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $8 | 54% |
| Jun 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| May 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| May 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| Mar 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| Mar 14, 2024 | Scotiabank | initiate | — → Sector Outperform | $13 | 55% |
| Mar 13, 2024 | Scotiabank | initiate | — → Sector Outperform | $13 | 55% |
| Mar 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $47 | 44% |
| Feb 8, 2024 | Jefferies | initiate | — → Buy | $15 | 52% |
| Oct 11, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $47 | 44% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Jun 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| May 30, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| May 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Apr 28, 2023 | Ladenburg Thalmann | maintain | — → Buy | $14 | 45% |
| Mar 23, 2023 | Piper Sandler | maintain | — → Overweight | $6 | 54% |
| Mar 23, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $35 | 44% |
| Feb 8, 2023 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Sep 15, 2022 | Ladenburg Thalmann | initiate | — → Buy | $8 | 45% |
| May 16, 2022 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Oct 21, 2021 | William Blair | initiate | — → Outperform | $0 | 48% |
| Jul 13, 2021 | HC Wainwright & Co. | initiate | — → Buy | $51 | 44% |
| Jul 6, 2021 | Piper Sandler | initiate | — → Overweight | $23 | 54% |
Price Target Trend
May 14, 2026 Latest: $7 Oct 24, 2026
EPS Estimates
0y $-2.85
Lo: $-2.85 Hi: $-2.85
1 analysts +1y $-0.90
Lo: $-0.90 Hi: $-0.90
1 analysts ▲1
0q $-0.32
Lo: $-0.32 Hi: $-0.32
1 analysts ▲1
+1q $-0.29
Lo: $-0.29 Hi: $-0.29
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days